Actinium Pharmaceuticals (NYSE: ATNM) is a clinical-stage biopharmaceutical company engaged in developing innovative targeted payload immunotherapies for the treatment of advanced cancers. The company’s radio-immunotherapy product candidates are based on the combination of the cancer targeting precision of monoclonal antibodies (mAb) that seek out specific types of cells combined with the cytotoxic killing power of … Continue reading “Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Starts Presentation at 30th Annual ROTH Conference”
AxoGen (NASDAQ: AXGN) is engaged in innovative surgical solutions for peripheral nerve injuries. AxoGen’s portfolio of products includes Avance®Nerve Graft, AxoGuard® Nerve Connector, AxoGuard® Nerve Protector, and Avive™ Soft Tissue Membrane. Along with these core surgical products, the company also offers AxoTouch™ Two-Point Discriminator and AcroVal™ Neurosensory & Motor Testing System. AxoGen’s suite of evaluation … Continue reading “AxoGen, Inc. (NASDAQ: AXGN) Starts Presentation at 30th Annual ROTH Conference”
Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF), a company focused on the development and implementation of proprietary technologies for the energy industry, today announced details regarding the components and features of its anticipated blockchain based oil & gas supply management platform, PetroBLOQ. Among other highlights, some of the targeted capabilities of the PetroBLOQ platform include … Continue reading “NetworkNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Unveils Details of PetroBLOQ Platform’s Key Features”
Moleculin Biotech (NASDAQ: MBRX) is a clinical stage pharmaceutical company focused on development of anti-cancer drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. The company’s lead product candidate is Annamycin, an anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia. Moleculin also has WP1066 … Continue reading “Moleculin Biotech, Inc. (NASDAQ: MBRX) Starts Presentation at 30th Annual ROTH Conference”
NeoGenomics (NASDAQ: NEO) provides cancer genetics testing and information services, offering one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer. The company is engaged in serving the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks and managed care organizations throughout … Continue reading “NeoGenomics, Inc. (NASDAQ: NEO) Starts Presentation at 30th Annual ROTH Conference”
SG Blocks (NASDAQ: SGBX) is engaged in the advancement and promotion of code-engineered cargo shipping containers for safe and sustainable construction. The company provides a product that surpasses many of the standard building code requirements and additionally supports developers, architects, builders and owners in attaining greener construction; quicker execution; and stronger, higher-value buildings. Each of … Continue reading “SG Blocks, Inc. (NASDAQ: SGBX) Starts Presentation at 30th Annual ROTH Conference”
Imprimis Pharmaceuticals (NASDAQ: IMMY) engages in the development, production, and sale of medications high quality innovative medications in the United States. The company’s unique business model increases patient access and affordability to many critical medicines. Headquartered in San Diego, California, Imprimis owns and operates production facilities located in California and New Jersey. For more information … Continue reading “Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) Starts Presentation at 30th Annual ROTH Conference”
Anavex Life Sciences (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company engaged in the development of drug candidates for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer. ANAVEX®2-73, the company’s lead drug candidate, has successfully completed a phase 2 clinical trial for … Continue reading “Anavex Life Sciences Corp. (NASDAQ: AVXL) Starts Presentation at 30th Annual ROTH Conference”
ReneSola (NYSE: SOL) is an international brand engaged in the development, construction, operation and asset management of solar projects. ReneSola has teams in 10 countries, including major solar power markets like China, the United States, Canada, the United Kingdom, France, Spain, Turkey, Poland, Japan and Thailand. The company is leveraging its global presence and widespread … Continue reading “ReneSola Ltd. (NYSE: SOL) Starts Presentation at 30th Annual ROTH Conference”
LivePerson (NASDAQ: LPSN) provides mobile and online messaging technologies that power digital communication between brands and consumers in the United States, in the United Kingdom, the Asia-Pacific, Latin America and Western Europe. Its cloud-based platform, LiveEngage, enables businesses to create a connection with consumers by offering messaging as a preferred channel of communication. LiveEngage reduces … Continue reading “LivePerson, Inc. (NASDAQ: LPSN) Starts Presentation at 30th Annual ROTH Conference”